Abstract:BACKGROUND:Treatment of the disrupted intrasynovial flexor tendon is troublesome and can be complicated by the rupture of weak repairs and the formation of adhesions. The central issue underlying the unsatisfactory outcomes is the lack of sufficient healing capacity, which prohibits aggressive postoperative tendon motion. Transfer of genes that are critical to healing by means of an efficient vector system offers a promising way of strengthening the repair. The purpose of the present study was to transfer the basic fibroblast growth factor gene through the adeno-associated viral-2 vector to injured digital flexor tendons and to investigate its effects on the healing strength of the tendon and on adhesion formation in a clinically relevant injury model.METHODS:One hundred and twenty-eight long toes from sixty-four white leghorn chickens were used. The flexor digitorum profundus tendons were cut completely in the digital sheath area and were repaired with the modified Kessler method. In Group 1, a total of 2 x 10(9) particles of adeno-associated viral vector harboring the basic fibroblast growth factor gene were injected into both ends of the cut tendon. In Group 2, the same amount of adeno-associated viral vector carrying the luciferase gene was injected. In Group 3 (the non-injection control group), the tendons were sutured without any injection. At the end of two, four, eight, and twelve weeks, the toes were harvested and the tendons were tested for determination of the load-to-failure strength. At the end of eight and twelve weeks, the energy required to flex the toes was tested. The morphology regarding healing status and adhesions around the tendon were evaluated at two, four, eight, and twelve weeks.RESULTS:The ultimate strength of repaired tendons that had been treated with adeno-associated viral vector-basic fibroblast growth factor was significantly greater than that of tendons that had been treated with the sham vector or simple repair both during the early healing period (two weeks, p < 0.01; four weeks, p < 0.01) and a later period (eight weeks, p < 0.05). At four weeks, the strength of tendons that had been treated with adeno-associated viral vector-basic fibroblast growth factor (8.9 +/- 1.9 N) was significantly greater than that of tendons that had been treated with sham vector (6.1 +/- 1.0 N) (p < 0.01) or simple suture (5.7 +/- 1.1 N) (p < 0.001). Statistically, the grading of adhesions was the same among all three groups at four and eight weeks, but at twelve weeks it was significantly less severe for tendons that had been treated with adeno-associated viral vector-basic fibroblast growth factor than for those that had been treated with simple suture (p < 0.05). The energy that was required to flex the toes after treatment with adeno-associated viral vector-basic fibroblast growth factor was not increased at eight or twelve weeks compared with that in the controls.CONCLUSIONS:The present study demonstrates that basic fibroblast growth factor gene transfer to digital flexor tendons by means of adeno-associated viral vector-2 significantly increases healing strength during the critical tendon healing period but does not increase adhesion formation.

Treatment of Adhesions after Achilles Tendon Injury Using Focused Ultrasound with Targeted Bfgf Plasmid-Loaded Cationic Microbubbles

Integration of mesenchymal stem cell sheet and bFGF-loaded fibrin gel in knitted PLGA scaffolds favorable for tendon repair

Use of Cationic Microbubbles Targeted to P-selectin to Improve Ultrasound-Mediated Gene Transfection of Hvegf165 to the Ischemic Myocardium

Effects of Transforming Growth Factor-Beta 1 and Vascular Endothelial Growth Factor 165 Gene Transfer on Achilles Tendon Healing

Efficacy of Ultrasound Microbubble-HGF Complex for Treating Hepatic Fibrosis and Its Relation with Perfusion Weighted Imaging

Low-intensity Pulsed Ultrasound Therapy： a Potential Strategy to Stimulate Tendon-Bone Junction Healing

Basic Fgf or Vegf Gene Therapy Corrects Insufficiency in the Intrinsic Healing Capacity of Tendons

Adeno-Associated Virus-2-Mediated Bfgf Gene Transfer to Digital Flexor Tendons Significantly Increases Healing Strength

Optimization of Intrinsic and Extrinsic Tendon Healing Through Controllable Water-Soluble Mitomycin-C Release from Electrospun Fibers by Mediating Adhesion-Related Gene Expression.

Micro- and nano-environment dual-modulated anti-tendon adhesion barrier membranes

Simultaneous targeting of TGF-β1/PD-L1 via a hydrogel-nanoparticle system to remodel the ECM and immune microenvironment for limiting adhesion formation

Controlled delivery of mesenchymal stem cells and growth factors using a nanofiber scaffold for tendon repair

Hydrogel bioadhesives harnessing nanoscale phase separation for Achilles tendon repairing

Improved Tendon Healing By A Combination Of Tanshinone Iia And Mir-29b Inhibitor Treatment Through Preventing Tendon Adhesion And Enhancing Tendon Strength

The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound-targeted microbubble destruction in rats

Tissue reactions of adenoviral, adeno-associated viral, and liposome-plasmid vectors in tendons and comparison with early-stage healing responses of injured flexor tendons.

Tissue Targeting and Ultrasound-Targeted Microbubble Destruction Delivery of Plasmid DNA and Transfection in Vitro

Three-Dimensional Tendon Scaffold Loaded with TGF-beta 1 Gene Silencing Plasmid Prevents Tendon Adhesion and Promotes Tendon Repair

Enhanced Gene Delivery into Skeletal Muscles with Ultrasound and Microbubble Techniques

MicroRNA-21-3p Engineered Umbilical Cord Stem Cell-Derived Exosomes Inhibit Tendon Adhesion

Synergistic Effects of Ultrasound-Targeted Microbubble Destruction and TAT Peptide on Gene Transfection: an Experimental Study in Vitro and in Vivo.